Medical Condition News

RSS

Fear of increased tobacco industry influence over policymakers due to business-friendly 'Better Regulation' reforms

Experts have urged the European Commission to ensure it focuses on public health when developing policies, rather than succumbing to pressure from the tobacco industry.

27 Feb 2010

Blacks less likely to know they have atrial fibrillation or about use of warfarin

A large nationwide study that includes neurologists from Mayo Clinic has found that blacks are substantially less likely than whites to know that they have atrial fibrillation or to use warfarin, the most common treatment for the condition. Atrial fibrillation, an abnormal heart rhythm, significantly increases risk of stroke. Warfarin is known to reduce that risk.

27 Feb 2010

University of Michigan Health System opens new facility for eye care, diabetes research

On March 1, the first eye patients will enter an innovative new $132 million facility that expands the University of Michigan Health System's capacity for eye care, research and education, and unites diabetes researchers as they work to accelerate the search for a cure and prevention of diabetes.

27 Feb 2010

Minimally-invasive procedure as effective as gold standard for treating carotid artery blockages: Study

A major study shows that a minimally-invasive procedure is as effective and safe as the gold standard for treating blockages of the carotid artery, giving patients who prefer a less invasive procedure a proven alternative.

27 Feb 2010

Thomas Jefferson University Hospital CLP receives Outstanding Performance Award

Adam Berger, M.D., a Cancer Liaison Physician (CLP) at Thomas Jefferson University Hospital, recently received an Outstanding Performance Award for going above and beyond the scope of the normal duties of serving as a liaison between the hospital's cancer program and the American College of Surgeons Commission on Cancer (CoC).

27 Feb 2010

Stroke incidence and treatment: Racial and geographic disparities

Blacks are more likely to have an undiagnosed key risk factor for stroke and are more likely to have a stroke than whites, according to two studies presented at the American Stroke Association's International Stroke Conference 2010.

27 Feb 2010

Phadia AB plans to provide access for specialists to peanut allergen components

Today, at the 2010 Annual Meeting of The American Academy of Allergy, Asthma & Immunology (AAAAI) Phadia, the world leader in in vitro allergy diagnostics, announced plans to provide access for specialists to peanut allergen components. These plans support Phadia’s goal to expand collaboration with allergy and immunology specialists in order to advance the understanding of the clinical utility of allergen component test results.

27 Feb 2010

UAMS researchers identify age-related mechanism as primary cause of osteoporosis

Marking a shift in decades of thought on the cause of osteoporosis, researchers at the University of Arkansas for Medical Sciences have identified an age-related mechanism - not a decrease of the hormone estrogen - as the primary culprit.

27 Feb 2010

For people who carry common gene variants, smoking increases risk of aneurysm

For people who carry common gene variants, cigarette smoking greatly increases the risk that a blood vessel in the brain will weaken and balloon out - called an aneurysm - which could be life-threatening if it ruptures, according to research presented at the American Stroke Association's International Stroke Conference 2010.

27 Feb 2010

African-Americans more likely to have highest stroke rate compared with Caucasians

African-Americans age 65 and younger are more than twice as likely to have a stroke compared with Caucasians in any region, and people who have a stroke are more likely to die in the South than elsewhere, according to researchers at the University of Alabama at Birmingham School of Public Health.

27 Feb 2010

Overall incidence of stroke, heart attack and death similar in carotid endarterectomy and stenting procedures

The two major procedures for opening blocked neck arteries to restore blood flow to the brain proved similar in overall long-term safety and efficacy, but showed differences in stroke and heart attack in the weeks following the procedure, according to late-breaking science presented at the American Stroke Association's International Stroke Conference 2010.

27 Feb 2010

CREST stroke prevention trial: Seminal and robust

The CREST trial that compared traditional surgery with less-invasive stenting to clear dangerously clogged carotid arteries in the neck is being called "seminal and robust."

27 Feb 2010

MLL cancer cells rely on normal protein to proliferate

Researchers have found that one particularly aggressive type of blood cancer, mixed lineage leukemia (MLL), has an unusual way to keep the molecular motors running. The cancer cells rely on the normal version of an associated protein to stay alive.

27 Feb 2010

Acculis' new device for destroying unwanted tissues receives European CE Mark clearance

Acculis Limited today announced the regulatory clearance of its revolutionary new device for destroying unwanted tissues, such as liver tumours. The clearance under the European CE Mark system allows the company to begin deliveries for treating patients throughout Europe and elsewhere where the CE Mark system is recognised. The device is a single high power high frequency 2.45GHz microwave needle that burns a 5cm sphere of tissue in just 5 minutes which is between 3 to 10 times faster than old school radiofrequency based systems or lower frequency 915MHz microwave systems.

27 Feb 2010

Chronic stroke impairment: Intensive, repetitive rehabilitation exercises may benefit arms, legs and cognitive function

High-intensity, repetitive rehabilitation exercises can help stroke survivors significantly improve functioning in their paralyzed arm and in their quality of life — even years after their disabling event, according to late-breaking science results presented at the American Stroke Association's International Stroke Conference 2010.

27 Feb 2010

Shire receives marketing approval from FDA for VPRIV

Shire plc, the global specialty biopharmaceutical company, announced today that the U.S. Food and Drug Administration has granted marketing approval for VPRIV, a human cell line derived enzyme replacement therapy (ERT) for the long-term treatment of Type 1 Gaucher disease in pediatric and adult patients.

27 Feb 2010

Neurogenesis linked to drug addiction and relapse

Researchers at UT Southwestern Medical Center hope they have begun paving a new pathway in the fight against drug dependence. Their hypothesis - that increasing the normally occurring process of making nerve cells might prevent addiction - is based on a rodent study demonstrating that blocking new growth of specific brain nerve cells increases vulnerability for cocaine addiction and relapse.

27 Feb 2010

Synta Pharmaceuticals presents preclinical and clinical data of Hsp90 inhibitor STA-9090

Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that Dr. Geoffrey I. Shapiro of Dana-Farber Cancer Institute, presented preclinical and clinical data on STA-9090, a potent second-generation Hsp90 inhibitor, at IASLC (International Association for the Study of Lung Cancer) 10th Annual Targeted Therapies of the Treatment of Lung Cancer Meeting in Santa Monica, CA.

27 Feb 2010

NIH awards $3M grant to VCU Massey Cancer Center to develop test to measure health literacy of cancer patients

The National Institutes of Health has awarded the Virginia Commonwealth Massey Cancer Center a National Cancer Institute grant totaling nearly $3 million to develop a standardized test to measure health literacy among cancer patients.

27 Feb 2010

Federal officials focus on radiation practices at Florida clinic; Medical scan makers announce new efforts to prevent mistakes

Medicare regulations require that when patients receive some types of highly specialized cancer treatments, their radiation oncologist must be on site. But The New York Times reports that federal officials are investigating a Florida cancer clinic that billed Medicare for such treatments while the doctors were absent, sometimes on overseas trips.

27 Feb 2010

Medical Condition News

Fear of increased tobacco industry influence over policymakers due to business-friendly 'Better Regulation' reforms

Blacks less likely to know they have atrial fibrillation or about use of warfarin

University of Michigan Health System opens new facility for eye care, diabetes research

Minimally-invasive procedure as effective as gold standard for treating carotid artery blockages: Study

Thomas Jefferson University Hospital CLP receives Outstanding Performance Award

Stroke incidence and treatment: Racial and geographic disparities

Phadia AB plans to provide access for specialists to peanut allergen components

UAMS researchers identify age-related mechanism as primary cause of osteoporosis

For people who carry common gene variants, smoking increases risk of aneurysm

African-Americans more likely to have highest stroke rate compared with Caucasians

Overall incidence of stroke, heart attack and death similar in carotid endarterectomy and stenting procedures

CREST stroke prevention trial: Seminal and robust

MLL cancer cells rely on normal protein to proliferate

Acculis' new device for destroying unwanted tissues receives European CE Mark clearance

Chronic stroke impairment: Intensive, repetitive rehabilitation exercises may benefit arms, legs and cognitive function

Shire receives marketing approval from FDA for VPRIV

Neurogenesis linked to drug addiction and relapse

Synta Pharmaceuticals presents preclinical and clinical data of Hsp90 inhibitor STA-9090

NIH awards $3M grant to VCU Massey Cancer Center to develop test to measure health literacy of cancer patients

Federal officials focus on radiation practices at Florida clinic; Medical scan makers announce new efforts to prevent mistakes

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Latest News